港股市場個股詳情

06628 創勝集團-B

添加自選

1.780
+0.030+1.71%

未開盤 04/26 16:08 (北京)

7.77億總市值-1521市盈率TTM

創勝集團-B股票討論區

登錄發表評論

Christine Kho

2023/02/16 13:28

bottom

$創勝集團-B(06628.HK)$
bottom

Christine Kho

2023/02/16 10:10

high success rate

$創勝集團-B(06628.HK)$ backed by Lilly and Temasek, high success rate for Claudin 18.3

aiden_cole

2021/10/09 20:04

$創勝集團-B(06628.HK)$ On October 9, the CDE website showed that The application for clinical trial of MBOS TST005 injection was accepted by the Food and Drug Administration, and the indication is solid tumor. TST005 is the second bi-functional anti-PD-L1 and TGF-β trap fusion protein to initiate a global clinical study.

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

港股

綜合熱度